0001493152-26-020743
SEC filingChallenging year marked by persistent operating losses amid war-related disruptions, partially offset by government compensation and operational cash generation. Balance sheet strengthened through bank loan repayments and immaterial growth in deferred tax assets from carryforward losses.
InterCure Ltd. faced a challenging fiscal year 2025, defined by persistent operating losses influenced by war-related disruptions including southern facility damage. These pressures were partially mitigated by government compensation, which helped sustain operations despite the volatile environment.
Non-current assets saw an immaterial increase over the prior year, attributable primarily to changes in deferred tax assets—specifically, deferred taxes on carryforward losses. This adjustment arises from tax planning around accumulated losses, providing a non-cash benefit that bolsters long-term asset positioning without requiring immediate capital outlays. Such tax assets represent potential future value realization as profitability improves.
Management's focus remains on vendor relationships, where replacing or adding suppliers incurs additional costs and demands significant time and attention. This underscores the importance of stable partnerships in a regulated industry, where disruptions could amplify operational challenges. Overall, while numeric pressures from impairments and losses persisted, qualitative strides in debt reduction, tax asset recognition, and production planning signal a foundation for recovery, aligning with investor interests in sustainable growth amid geopolitical risks.